Format

Send to

Choose Destination
Cancer Lett. 2006 Jan 8;231(1):74-86.

A cDNA-microarray analysis of camptothecin resistance in glioblastoma cell lines.

Author information

1
Fenice Environmental Research Center, Via Ciro Menotti 48, 48023 Marina di Ravenna, Ravenna, Italy.

Abstract

Chemotherapy, as generally available, is of a limited value in curing malignant brain tumors (gliomas), which often develop resistance to drugs, becoming completely unresponsive to any standard therapeutic approach. Camptothecins, a family of topoisomerase I inhibitor drugs, represent a new promising treatment strategy and are currently under evaluation for testing the clinical efficacy. We selected a CPT-resistant sub-line (U87CPT-R) from U87-MG grade III-IV astrocytoma cells, and compared the expression profile of the two cell lines by cDNA-microarray, as a preliminary screening of the molecular mechanisms involved in the acquisition of CPT resistance in glioma cells. The relevant role of IL-1 beta overproduction as well as a generalised up-regulation of genes implicated in angiogenesis and inflammatory response are discussed in details.

PMID:
16356833
DOI:
10.1016/j.canlet.2005.01.017
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center